7-130277855-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001869.3(CPA2):c.726G>T(p.Lys242Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA2 | NM_001869.3 | c.726G>T | p.Lys242Asn | missense_variant | 8/11 | ENST00000222481.9 | NP_001860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.726G>T | p.Lys242Asn | missense_variant | 8/11 | 1 | NM_001869.3 | ENSP00000222481 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000807 AC: 2AN: 247898Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133528
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460770Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726476
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.726G>T (p.K242N) alteration is located in exon 8 (coding exon 8) of the CPA2 gene. This alteration results from a G to T substitution at nucleotide position 726, causing the lysine (K) at amino acid position 242 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at